Leukemia, Myelocytic, Acute
|
0.010 |
Biomarker
|
disease |
BEFREE |
The regulatory effects of overexpressed NUP205 on proliferative potential and cell cycle progression of pAML and THP-1 cells transfected with si-SNHG1 were explored by gain-of-function experiments.
|
31298340 |
2019 |
Amyotrophic Lateral Sclerosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Double immunofluorescent analyses revealed nuclear retention and apparent colocalization of RanGap1 with Nup205, Gp210 with Nup205, and partial colocalization of Nup205 with Nup107; most of the ischemic changes above were similar to those observed in patients with C9orf72-genetic amyotrophic lateral sclerosis.
|
28029704 |
2017 |
Retinoblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Besides the well-established driver genes RB1 (13q-loss) and MYCN (2p-gain) we identified CRB1 and NEK7 (1q-gain), SOX4 (6p-gain) and NUP205 (7q-gain) as novel retinoblastoma driver candidates.
|
27115612 |
2016 |
Malignant neoplasm of lung
|
0.010 |
Biomarker
|
disease |
BEFREE |
Taken together, our findings indicate that TMEM209 overexpression and TMEM209-NUP205 interaction are critical drivers of lung cancer proliferation, suggesting a promising new target for lung cancer therapy.
|
22719065 |
2012 |
Carcinoma of lung
|
0.010 |
Biomarker
|
disease |
BEFREE |
Taken together, our findings indicate that TMEM209 overexpression and TMEM209-NUP205 interaction are critical drivers of lung cancer proliferation, suggesting a promising new target for lung cancer therapy.
|
22719065 |
2012 |
Primary malignant neoplasm of lung
|
0.010 |
Biomarker
|
disease |
BEFREE |
Taken together, our findings indicate that TMEM209 overexpression and TMEM209-NUP205 interaction are critical drivers of lung cancer proliferation, suggesting a promising new target for lung cancer therapy.
|
22719065 |
2012 |
Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Waist-Hip Ratio
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Systolic Pressure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Venous Thromboembolism
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Identification of unique venous thromboembolism-susceptibility variants in African-Americans.
|
28203683 |
2017 |
Finding of Mean Corpuscular Hemoglobin
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Seventy-five genetic loci influencing the human red blood cell.
|
23222517 |
2012 |
Corpuscular Hemoglobin Concentration Mean
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Seventy-five genetic loci influencing the human red blood cell.
|
23222517 |
2012 |
Paget Disease
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association identifies three new susceptibility loci for Paget's disease of bone.
|
21623375 |
2011 |
Focal glomerulosclerosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Chronic kidney disease stage 5
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Steroid-resistant nephrotic syndrome
|
0.120 |
GeneticVariation
|
disease |
BEFREE |
Recently, it was discovered that mutations of NUP93 and NUP205, encoding 2 proteins of the inner ring subunit of the nuclear pore complex (NPC), cause SRNS.
|
30179222 |
2018 |
Steroid resistant nephrotic syndrome of childhood
|
0.120 |
GeneticVariation
|
disease |
BEFREE |
Recently, it was discovered that mutations of NUP93 and NUP205, encoding 2 proteins of the inner ring subunit of the nuclear pore complex (NPC), cause SRNS.
|
30179222 |
2018 |
Steroid-resistant nephrotic syndrome
|
0.120 |
Biomarker
|
disease |
BEFREE |
Here we identify in eight families with SRNS mutations in NUP93, its interaction partner NUP205 or XPO5 (encoding exportin 5) as hitherto unrecognized monogenic causes of SRNS.
|
26878725 |
2016 |
Steroid resistant nephrotic syndrome of childhood
|
0.120 |
Biomarker
|
disease |
BEFREE |
Here we identify in eight families with SRNS mutations in NUP93, its interaction partner NUP205 or XPO5 (encoding exportin 5) as hitherto unrecognized monogenic causes of SRNS.
|
26878725 |
2016 |
Steroid-resistant nephrotic syndrome
|
0.120 |
Biomarker
|
disease |
HPO |
|
|
|
Steroid resistant nephrotic syndrome of childhood
|
0.120 |
Biomarker
|
disease |
HPO |
|
|
|
Osteitis Deformans
|
0.400 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association identifies three new susceptibility loci for Paget's disease of bone.
|
21623375 |
2011 |
Osteitis Deformans
|
0.400 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association identifies three new susceptibility loci for Paget's disease of bone.
|
21623375 |
2011 |
Osteitis Deformans
|
0.400 |
Biomarker
|
disease |
CTD_human |
Genome-wide association identifies three new susceptibility loci for Paget's disease of bone.
|
21623375 |
2011 |
NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE
|
0.500 |
GermlineCausalMutation
|
disease |
ORPHANET |
Mutations in nuclear pore genes NUP93, NUP205 and XPO5 cause steroid-resistant nephrotic syndrome.
|
26878725 |
2016 |